The scientist’s investigation covers issues in Internal medicine, Gastroenterology, Surgery, Cirrhosis and Immunology. Dominique Valla studied Internal medicine and Hepatitis C virus that intersect with Hepatitis C. Dominique Valla has researched Gastroenterology in several fields, including Hepatitis B and Liver biopsy.
His research in Cirrhosis intersects with topics in Hepatocellular carcinoma, Liver function and Model for End-Stage Liver Disease. His work on Hepatitis B virus, Interferon and Virus as part of general Immunology study is frequently linked to Vacuole, therefore connecting diverse disciplines of science. He focuses mostly in the field of Portal hypertension, narrowing it down to matters related to Pathology and, in some cases, Nodular regenerative hyperplasia.
Dominique Valla mainly focuses on Internal medicine, Gastroenterology, Cirrhosis, Surgery and Portal hypertension. His work on Liver disease, Budd–Chiari syndrome, Ascites and Liver transplantation is typically connected to In patient as part of general Internal medicine study, connecting several disciplines of science. His work carried out in the field of Gastroenterology brings together such families of science as Fibrosis, Pathology and Immunology.
His Cirrhosis research includes themes of Endocrinology, Hemodynamics, Cardiology, Hepatocellular carcinoma and Prospective cohort study. As part of his studies on Surgery, Dominique Valla frequently links adjacent subjects like Varices. His research combines Radiology and Portal hypertension.
Dominique Valla mostly deals with Internal medicine, Gastroenterology, Cirrhosis, Portal hypertension and Liver disease. His study in the fields of Portal vein thrombosis, Budd–Chiari syndrome, Liver transplantation and Hepatology under the domain of Internal medicine overlaps with other disciplines such as In patient. Dominique Valla combines subjects such as Prospective cohort study and Fatty liver with his study of Gastroenterology.
His Cirrhosis study integrates concerns from other disciplines, such as Fibrosis, Microvesicle, Retrospective cohort study and Ascites. His Portal hypertension study combines topics from a wide range of disciplines, such as Thrombosis, Radiology and Elastography. His studies in Liver disease integrate themes in fields like Chronic liver disease and Model for End-Stage Liver Disease.
Dominique Valla spends much of his time researching Internal medicine, Cirrhosis, Gastroenterology, Portal hypertension and Hepatology. He has researched Internal medicine in several fields, including Endocrinology and Transaminase. His Cirrhosis research incorporates elements of Liver disease, Liver transplantation, Decompensation and Ascites.
His Gastroenterology research includes elements of Prospective cohort study and Liver injury. Dominique Valla works mostly in the field of Hepatology, limiting it down to topics relating to Pathology and, in certain cases, Nodular regenerative hyperplasia, Vascular disease and Incomplete septal cirrhosis, as a part of the same area of interest. His Portal vein thrombosis research is multidisciplinary, incorporating perspectives in Varices and Venous thrombosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The burden of liver disease in Europe. A review of available epidemiological data.
Martin Blachier;Henri Leleu;Markus Peck-Radosavljevic;Dominique Charles Valla.
Journal of Hepatology (2013)
Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis
Rami Moucari;Tarik Asselah;Dominique Cazals–Hatem;Hélène Voitot.
Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis
Erica Villa;Calogero Cammà;Marco Marietta;Monica Luongo.
Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD
François Durand;Dominique Valla.
Journal of Hepatology (2005)
Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients.
Rami Moucari;Rami Moucari;Vincent Mackiewicz;Olivier Lada;Olivier Lada;Marie-Pierre Ripault;Marie-Pierre Ripault.
Regression of Liver Fibrosis after Biliary Drainage in Patients with Chronic Pancreatitis and Stenosis of the Common Bile Duct
Pascal Hammel;Anne Couvelard;Dermot O'Toole;Anne Ratouis.
The New England Journal of Medicine (2001)
Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation
C Francoz;J Belghiti;V Vilgrain;D Sommacale.
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.
Richard Moreau;Francois Durand;Thierry Poynard;Christian Duhamel.
Deleterious effects of beta‐blockers on survival in patients with cirrhosis and refractory ascites
Thomas Sersté;Christian Melot;Claire Francoz;Claire Francoz;François Durand;François Durand.
Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men.
Jean-François Colin;Dominique Cazals-Hatem;Marie Anne Loriot;Michèle Martinot-Peignoux.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: